ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 146 filers reported holding ITEOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,268,457 | -20.4% | 207,165 | -3.8% | 0.00% | 0.0% |
| Q2 2023 | $2,851,460 | -64.4% | 215,367 | -63.4% | 0.00% | -50.0% |
| Q1 2023 | $8,010,314 | -32.6% | 588,561 | -3.3% | 0.00% | -33.3% |
| Q4 2022 | $11,885,957 | +14.4% | 608,600 | +11.6% | 0.00% | 0.0% |
| Q3 2022 | $10,386,000 | -0.5% | 545,179 | +7.6% | 0.00% | 0.0% |
| Q2 2022 | $10,437,000 | +159.4% | 506,630 | +305.2% | 0.00% | +200.0% |
| Q1 2022 | $4,024,000 | +84.0% | 125,023 | +166.2% | 0.00% | 0.0% |
| Q4 2021 | $2,187,000 | +946.4% | 46,967 | +506.5% | 0.00% | – |
| Q3 2021 | $209,000 | – | 7,744 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $88,134,000 | 30.12% |
| MPM BioImpact LLC | 1,745,943 | $56,184,000 | 15.08% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $30,169,000 | 6.04% |
| Boxer Capital, LLC | 3,192,058 | $102,720,000 | 5.28% |
| Octagon Capital Advisors LP | 450,776 | $14,506,000 | 3.14% |
| RA Capital Management | 4,417,259 | $142,147,000 | 3.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 138,843 | $4,468,000 | 1.85% |
| BVF INC/IL | 1,400,201 | $45,058,000 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 234,150 | $7,535,000 | 1.34% |
| Rubric Capital Management LP | 822,112 | $26,456,000 | 0.96% |